These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 27989076)
1. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse. Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076 [TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse. Lim HG; Choi SY; Yoon EJ; Kim SH; Kim YJ Tissue Eng Part A; 2013 Nov; 19(21-22):2339-48. PubMed ID: 23672462 [TBL] [Abstract][Full Text] [Related]
3. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts. Lee C; Ahn H; Kim SH; Choi SY; Kim YJ Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697 [TBL] [Abstract][Full Text] [Related]
4. Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue. Kim MS; Lim HG; Kim YJ Eur J Cardiothorac Surg; 2016 Mar; 49(3):894-900. PubMed ID: 25994817 [TBL] [Abstract][Full Text] [Related]
5. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium. Lim HG; Kim SH; Choi SY; Kim YJ Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607 [TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy for novel combined anticalcification treatment of glutaraldehyde-fixed cardiac xenograft using humanized mice. Lim HG; Choi SY; Jeong S; Shin JS; Park CG; Kim YJ J Biomater Appl; 2015 Feb; 29(7):929-40. PubMed ID: 25245780 [TBL] [Abstract][Full Text] [Related]
7. Differences in xenoreactive immune response and patterns of calcification of porcine and bovine tissues in α-Gal knock-out and wild-type mouse implantation models. Kim MS; Jeong S; Lim HG; Kim YJ Eur J Cardiothorac Surg; 2015 Sep; 48(3):392-9. PubMed ID: 25549993 [TBL] [Abstract][Full Text] [Related]
16. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597 [TBL] [Abstract][Full Text] [Related]
17. Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration? Lee W; Long C; Ramsoondar J; Ayares D; Cooper DK; Manji RA; Hara H Xenotransplantation; 2016 Sep; 23(5):370-80. PubMed ID: 27511593 [TBL] [Abstract][Full Text] [Related]
18. Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model. Park CS; Kim YJ; Lee JR; Lim HG; Chang JE; Jeong S; Kwon N Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):391-399. PubMed ID: 28505294 [TBL] [Abstract][Full Text] [Related]
19. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. Weissenstein C; Human P; Bezuidenhout D; Zilla P J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041 [TBL] [Abstract][Full Text] [Related]
20. Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves. McGregor C; Byrne G; Rahmani B; Chisari E; Kyriakopoulou K; Burriesci G Acta Biomater; 2016 Sep; 41():204-209. PubMed ID: 27268480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]